Australia markets closed

PharmAust Limited (PAA.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.22000.0000 (0.00%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 86.90M
Enterprise value 85.25M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.36
Price/book (mrq)11.65
Enterprise value/revenue 30.19
Enterprise value/EBITDA -9.98

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3171.60%
S&P500 52-week change 322.38%
52-week high 30.5350
52-week low 30.0655
50-day moving average 30.3211
200-day moving average 30.1594

Share statistics

Avg vol (3-month) 31.54M
Avg vol (10-day) 31.7M
Shares outstanding 5395.01M
Implied shares outstanding 6412.97M
Float 8258.55M
% held by insiders 131.46%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 330 Oct 2015

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -177.28%
Operating margin (ttm)-187.47%

Management effectiveness

Return on assets (ttm)-31.99%
Return on equity (ttm)-101.98%

Income statement

Revenue (ttm)3.71M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-11.20%
Gross profit (ttm)N/A
EBITDA -4.7M
Net income avi to common (ttm)-7.75M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.45M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.55
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-1.54M
Levered free cash flow (ttm)-898.99k